Correlation Between Cardiff Oncology and Enzolytics

Can any of the company-specific risk be diversified away by investing in both Cardiff Oncology and Enzolytics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardiff Oncology and Enzolytics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cardiff Oncology and Enzolytics, you can compare the effects of market volatilities on Cardiff Oncology and Enzolytics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardiff Oncology with a short position of Enzolytics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardiff Oncology and Enzolytics.

Diversification Opportunities for Cardiff Oncology and Enzolytics

-0.06

Correlation Coefficient

Cardiff Oncology  Enzolytics

Good diversification

The 3 months correlation between Cardiff and Enzolytics is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Cardiff Oncology and Enzolytics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enzolytics and Cardiff Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardiff Oncology are associated (or correlated) with Enzolytics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enzolytics has no effect on the direction of Cardiff Oncology i.e., Cardiff Oncology and Enzolytics go up and down completely randomly.

Pair Corralation between Cardiff Oncology and Enzolytics

Given the investment horizon of 90 days Cardiff Oncology is expected to generate 15.92 times less return on investment than Enzolytics. But when comparing it to its historical volatility, Cardiff Oncology is 6.19 times less risky than Enzolytics. It trades about 0.06 of its potential returns per unit of risk. Enzolytics is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  0.02  in Enzolytics on September 12, 2025 and sell it today you would earn a total of  0.01  from holding Enzolytics or generate 50.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cardiff Oncology  vs.  Enzolytics

Cardiff Oncology

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in Cardiff Oncology are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain fundamental indicators, Cardiff Oncology reported solid returns over the last few months and may actually be approaching a breakup point.

Enzolytics

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Enzolytics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Enzolytics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cardiff Oncology and Enzolytics

The main advantage of trading using opposite Cardiff Oncology and Enzolytics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardiff Oncology position performs unexpectedly, Enzolytics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzolytics will offset losses from the drop in Enzolytics' long position.

The idea behind Cardiff Oncology and Enzolytics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.